Skip to main content
Veterinary Medicines

SALMOPAST

Authorised
  • Mannheimia haemolytica, Inactivated
  • Pasteurella multocida, serotype D4, antigens
  • Pasteurella multocida, serotype A3, antigens
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, antigens O and H
  • Salmonella enterica, subsp. enterica, serovar Dublin, antigens O and H

Product identification

Medicine name:
SALMOPAST
Active substance:
  • Mannheimia haemolytica, Inactivated
  • Pasteurella multocida, serotype D4, antigens
  • Pasteurella multocida, serotype A3, antigens
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, antigens O and H
  • Salmonella enterica, subsp. enterica, serovar Dublin, antigens O and H
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, Inactivated
    0.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Pasteurella multocida, serotype D4, antigens
    0.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Pasteurella multocida, serotype A3, antigens
    0.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, antigens O and H
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • Salmonella enterica, subsp. enterica, serovar Dublin, antigens O and H
    1.50
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
    • Goat
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB
  • QI03AB
  • QI04AB
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8588182 8/1981
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022